Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Gemtuzumab Ozogamicin in Combination with Vorinostat and Azacitidine As Induction and Post-Remission Therapy in Older Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Phase 1 Study Walter, R. B., Medeiros, B. C., Gardner, K. M., Estey, E. H. AMER SOC HEMATOLOGY. 2011: 670
View details for Web of Science ID 000299597102136